개장 전 · Aug 17, 2026, EDT · 정보기술 · 매수

Insulet Device Correction Seen as Setback, Long-Term Targets Intact, RBC Says

[출처/시간] MT Newswires - 12:51 PM ET, 05/27/2026 12:51 PM EDT, 05/27/2026 (MT Newswires) -- Insulet's (PODD) voluntary global medical device correction affecting Omnipod 5, DASH and Eros Pods due to manufacturing issues that could result in insulin under-delivery is disappointing but does not alter the company's long-term outlook, RBC Capital Markets said in a note. RBC analysts said about 8.5% of 2025 global Omnipod Pod production is impacted, w

뉴스 | admin | May 27, 2026

Insulet Device Correction Seen as Setback, Long-Term Targets Intact, RBC Says

[출처/시간] MT Newswires - 12:51 PM ET, 05/27/2026

12:51 PM EDT, 05/27/2026 (MT Newswires) -- Insulet's (PODD) voluntary global medical device correction affecting Omnipod 5, DASH and Eros Pods due to manufacturing issues that could result in insulin under-delivery is disappointing but does not alter the company's long-term outlook, RBC Capital Markets said in a note.

RBC analysts said about 8.5% of 2025 global Omnipod Pod production is impacted, with 24 serious adverse events reported but no deaths. The company expects up to $50 million in non-GAAP costs, primarily in the second quarter.

Insulet said the issue will not affect its 2026 guidance or 2026-2028 targets and added it has sufficient supply to replace impacted Pods without disrupting shipments, product availability or new customer starts.

RBC maintained its outperform rating and $280 price target.

Insulet shares were down by more than 7% in Wednesday trading.

Price: 142.69, Change: -11.12, Percent Change: -7.23

Related Tags

SCHW_NEWS

3 Comments

김지나 Aug 15, 2026 at 4:39 am ↩

리포트 잘 봤습니다. 경쟁사 비교 차트가 한눈에 들어와서 좋네요. 다음 분기 가이던스가 어떻게 나올지 궁금합니다.
장창국 Aug 16, 2026 at 4:39 am ↩

같은 섹터의 ETF 흐름도 함께 보면 더 좋을 것 같습니다.
KRinus Aug 17, 2026 at 1:39 am ↩

의견 감사합니다. 곧 섹터 ETF 비교 차트를 별도 임베드로 추가할 예정입니다.

Related Tags

3 Comments

Leave a Comment

Related Posts